<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>PRWeb.com Press Release Feed - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/109235.xml</link>
<description>PRWeb.com Press Release Feed - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>CBDM.T&#174;, The Market and Business Intelligence Company Reviews The Vaccine Market</title>
     <link>http://www.prweb.com/releases/vaccines/cbdmt/prweb2314824.htm</link><description>   <![CDATA[ <P>According to CBDM.T&#174;, the market and business intelligence company, the vaccine market is a huge and growing market valued at &#8364;16 billion in 2008 with an annual growth of about 15 to 18%. The vaccine market could account for more than &#8364;25 billion by 2012. (PRWeb Apr 13, 2009)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/vaccines/cbdmt/prweb2314824.htm">http://www.prweb.com/releases/vaccines/cbdmt/prweb2314824.htm</a></P>]]>
                </description><pubDate>Mon, 13 Apr 2009 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/vaccines/cbdmt/prweb2314824.htm</guid>
        </item>
<item>
     <title>CBDM.T&#174;, the Market and Business Intelligence Company Reviews the Biofuel Market </title>
     <link>http://www.prweb.com/releases/cbdmt/biofuel/prweb1673024.htm</link><description>   <![CDATA[ <P>According to CBDM.T&#174;, the market and business intelligence company, the biofuel market is estimated at &#8364;33 billion with a double digit annual growth. The market consists of approximately 85% bioethanol and 15% biodiesel. Bioethanol is produced and consumed mainly in Brazil and North America. On the other hand, Europe is the world leader in biodiesel production and this fuel represents about &#190; of the European biofuels market. (PRWeb Nov 27, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/cbdmt/biofuel/prweb1673024.htm">http://www.prweb.com/releases/cbdmt/biofuel/prweb1673024.htm</a></P>]]>
                </description><pubDate>Thu, 27 Nov 2008 08:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/cbdmt/biofuel/prweb1673024.htm</guid>
        </item>
<item>
     <title>Algenics Receives 650k Euros of Oseo Fundings as Part of the Algohub Program, Led by the Roquette Group</title>
     <link>http://www.prweb.com/releases/2008/11/prweb1661884.htm</link><description>   <![CDATA[ <P>ALGENICS SAS has today announced it has been granted OSEO funding amounting to 650,000 Euros for its partnership in the ALGOHUB program, led by the ROQUETTE group. (PRWeb Nov 26, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/11/prweb1661884.htm">http://www.prweb.com/releases/2008/11/prweb1661884.htm</a></P>]]>
                </description><pubDate>Wed, 26 Nov 2008 08:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/11/prweb1661884.htm</guid>
        </item>
<item>
     <title>CBDM.T&#174;, The Market and Business Intelligence Company Reviews The Biomanufacturing Market</title>
     <link>http://www.prweb.com/releases/2008/09/prweb1320054.htm</link><description>   <![CDATA[ <P>According to CBDMT&#174;, the market and business intelligence company, contract biomanufacturing is a significant market estimated at &#8364;2.3 billion this year with an annual growth of about 10 to 15%. Pharmaceutical biomanufacturing could account for more than 20% of the global contract manufacturing market in 2012. (PRWeb Sep 15, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/09/prweb1320054.htm">http://www.prweb.com/releases/2008/09/prweb1320054.htm</a></P>]]>
                </description><pubDate>Mon, 15 Sep 2008 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/09/prweb1320054.htm</guid>
        </item>
<item>
     <title>CBDM.T&#174;, The Market and Business Intelligence Company Reviews The Enzyme Market </title>
     <link>http://www.prweb.com/releases/2008/07/prweb1078224.htm</link><description>   <![CDATA[ <P>According to CBDM.T&#174;, The market and business intelligence company,  the enzyme market is significant and estimated at &#8364;3.4 billion with an annual growth of about 6.5 to 10%. Enzymes are sold in many different industry segments. These segments are Detergents, Food, Feed, Technical, Pharmaceutical, Microorganisms and Biofuels. (PRWeb Jul 8, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/07/prweb1078224.htm">http://www.prweb.com/releases/2008/07/prweb1078224.htm</a></P>]]>
                </description><pubDate>Tue, 08 Jul 2008 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/07/prweb1078224.htm</guid>
        </item>
<item>
     <title>CBDM.T&#174;, the Market and Business Intelligence Company Announces the Opening of a New Office in Israel</title>
     <link>http://www.prweb.com/releases/2008/05/prweb968734.htm</link><description>   <![CDATA[ <P>To continue its growth in the life science industry, CBDM.T&#174; is expanding its team with a new Israeli partner, Olivier Soussan. &quot;The addition of Olivier to our team meets our customer&#039;s expectations to develop business in the very dynamic Life Science market in Israel&quot; says Philippe Tramoy, managing partner. (PRWeb May 26, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb968734.htm">http://www.prweb.com/releases/2008/05/prweb968734.htm</a></P>]]>
                </description><pubDate>Mon, 26 May 2008 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/05/prweb968734.htm</guid>
        </item>
<item>
     <title>CBDMT Announces The Invisible Revolution: White Biotechnology </title>
     <link>http://www.prweb.com/releases/2008/02/prweb717413.htm</link><description>   <![CDATA[ <P>From the first recombinant protein in the 70s, modern biotechnology and more particularly the industrial or white biotechnology is a real alternative technology for the development and the production of goods from renewable resources (in 2015 up to &#8364;300 billion in chemical product sales will be bioproduced). It will allow increasing energy and processing efficiency (cost-effectiveness, flexibility, cleanness, sustainability). So please think not only about pharmaceutical products when we are talking about the &#039;so trendy&#039; biotechnology market. The invisible white biotechnology revolution is going on. (PRWeb Feb 24, 2008)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2008/02/prweb717413.htm">http://www.prweb.com/releases/2008/02/prweb717413.htm</a></P>]]>
                </description><pubDate>Sun, 24 Feb 2008 08:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2008/02/prweb717413.htm</guid>
        </item>
<item>
     <title>CBDMT Announces Collaboration Agreement with BioAdvice </title>
     <link>http://www.prweb.com/releases/2006/05/prweb391993.htm</link><description>   <![CDATA[ <P>CBDM.T&#174; Ltd. (http://www.cbdmt.com) today announced that it has entered into a strategic collaboration with BioAdvice Ltd. (http://www.bioadviceonline.com). Under the agreement, CBDM.T&#174; and BioAdvice will not only identify but also audit some potential future partners or innovative technologies to be acquired or developed by their customers.This strategic collaboration is in line with our customer&#8217;s expectation of identifying innovative, relevant and industrially applicable technologies to be successful in the product innovation race. It will be focused on technologies and/or biotechnologies fitting with the improvement and the development of innovative products in the Life Science, Chemical and Cosmetics markets. (PRWeb May 31, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/05/prweb391993.htm">http://www.prweb.com/releases/2006/05/prweb391993.htm</a></P>]]>
                </description><pubDate>Wed, 31 May 2006 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2006/05/prweb391993.htm</guid>
        </item>
<item>
     <title>LifeScience-Consulting and CBDMT Enter Into a Joint Venture </title>
     <link>http://www.prweb.com/releases/2006/05/prweb383940.htm</link><description>   <![CDATA[ <P>LifeScience-Consulting Inc. (http://www.lifescience-consulting.com) is pleased to announce it has entered into a joint agreement with CBDM.T&#174; Ltd. (http://www.cbdmt.com). This exciting collaboration will enable a broader range of services to be offered to business development departments, financial analysts and top-managers in pharma, biotech, chemical industries and financial services. (PRWeb May 12, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/05/prweb383940.htm">http://www.prweb.com/releases/2006/05/prweb383940.htm</a></P>]]>
                </description><pubDate>Fri, 12 May 2006 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2006/05/prweb383940.htm</guid>
        </item>
<item>
     <title>Philippe Tramoy Joins InnoTune&#174; EEIG</title>
     <link>http://www.prweb.com/releases/2004/09/prweb158619.htm</link><description>   <![CDATA[ <P>To support its growth in the European biotech industry, InnoTune&#174;EEIG expands its core team with a new French partner, Philippe Tramoy. &#8220;The addition of Philippe to our team is in line with our customer&#8217;s expectations of growing our core competence in the life-science market with professionals.&#8221; says Lieven De Smedt, co-founder and managing partner. (PRWeb Sep 17, 2004)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2004/09/prweb158619.htm">http://www.prweb.com/releases/2004/09/prweb158619.htm</a></P>]]>
                </description><pubDate>Fri, 17 Sep 2004 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2004/09/prweb158619.htm</guid>
        </item>
</channel>
</rss>